Table 1 Fasting Plasma Lipid and Hormone Levels
From: Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics
Fasting Values | Control n = 9 | Diabetics n = 6 | Diabetics + ROSI n = 6 | ANOVA |
|---|---|---|---|---|
Age (years) | 36.4 ± 2.9 | 54.3 ± 4.2** | 54.3 ± 4.1** | 0.002 |
BMI (kg/m2) | 24.3 ± 3.0 | 32.2 ± 2.1** | 33.2 ± 2.0** | 0.007 |
Glucose (mmol/L) | 5.3 ± 0.15 | 8.84 ± 0.80* | 7.0 ± 0.59 | 0.003 |
Triglyceride (umol/L) | 1098 ± 177 | 2148 ± 399** | 2152 ± 535 | NS |
NEFA (umol/L) | 513 ± 41 | 650 ± 99 | 568 ± 61 | NS |
Insulin (pmol/L) | 70.5 ± 5.1 | 121.0 ± 28.6 | 86.7 ± 11.7 | NS |